RECOMBINATE 1000 IU

מדינה: ישראל

שפה: אנגלית

מקור: Ministry of Health

מרכיב פעיל:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

זמין מ:

TEVA MEDICAL MARKETING LTD.

קוד ATC:

B02BD02

טופס פרצבטיות:

POWDER FOR SOLUTION FOR INJECTION

מסלול נתינה (של תרופות):

I.V

תוצרת:

BAXTER S.A., BELGIUM

קבוצה תרפויטית:

COAGULATION FACTOR VIII

סממני תרפויטית:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

תאריך אישור:

2010-07-01